A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Our Community Bookmark and Share

City of Hope is turning science into practical benefit…For our current and future patients and our community

City of Hope Leads the Way in Research  
 
Jeffrey Weitzel, M.D. is Chief of the Division of Clinical Cancer Genetics at City of Hope. Dr. Weitzel's multidisciplinary clinical and research program emphasizes the recognition and assessment of people at increased risk for developing cancer because of family cancer history or personal risk factors. He is currently studying the incidence of breast cancer in Latina women. Learn more about Dr. Weitzel.
 
Amrita Krishnan, M.D., F.A.C.P., is Director of the Multiple Myeloma Program at City of Hope. Her work highlights the need for personalization in the treatment of multiple myeloma — the key is to tailor the therapy in the most appropriate way. Learn more about Dr. Krishnan.
 
Reducing Health Disparities
 
Population Sciences
The mission of the Department of Population Sciences is to advance the science and application of cancer etiology, prevention and outcomes, and reduce the burden of cancer and its sequelae across all populations, through collaborative multidisciplinary programs in clinical service, research and education. It’s divisions include Cancer Etiology, Center for Cancer Survivorship, CCARE, Clinical Cancer Genetics, Nursing Research and Education, Outcomes Research, and BMT Study.
 
Center of Community Alliance for Research and Education
CCARE implements specific best practice community strategies to reduce and eliminate inequalities in cancer outcomes. Our mission is to increase education and awareness of the most advanced practices in health care for all patients, bringing the best that City of Hope has to offer to underrepresented and underserved patients and communities.
 
Clinical Trials
At any given time, our researchers are conducting hundreds of clinical trials to test new treatments for cancer. Recruiting diverse participants to these trials allows us to better understand how cancer and its treatments impact different communities and people differently. Our clinical trials improve health.
 
 
Serving Our Latino Community
 
Given that cancer is the leading cause of death among Latinos in California, and recognizing that our primary service area is 46% Latino, we are taking more active steps to better understand and serve the Latino community.

Learn more about the current initiatives at City of Hope aimed at connecting with our Latino community.
 
Contact us at diversityandinclusion@coh.org for more information.

Our Community

City of Hope is turning science into practical benefit…For our current and future patients and our community

City of Hope Leads the Way in Research  
 
Jeffrey Weitzel, M.D. is Chief of the Division of Clinical Cancer Genetics at City of Hope. Dr. Weitzel's multidisciplinary clinical and research program emphasizes the recognition and assessment of people at increased risk for developing cancer because of family cancer history or personal risk factors. He is currently studying the incidence of breast cancer in Latina women. Learn more about Dr. Weitzel.
 
Amrita Krishnan, M.D., F.A.C.P., is Director of the Multiple Myeloma Program at City of Hope. Her work highlights the need for personalization in the treatment of multiple myeloma — the key is to tailor the therapy in the most appropriate way. Learn more about Dr. Krishnan.
 
Reducing Health Disparities
 
Population Sciences
The mission of the Department of Population Sciences is to advance the science and application of cancer etiology, prevention and outcomes, and reduce the burden of cancer and its sequelae across all populations, through collaborative multidisciplinary programs in clinical service, research and education. It’s divisions include Cancer Etiology, Center for Cancer Survivorship, CCARE, Clinical Cancer Genetics, Nursing Research and Education, Outcomes Research, and BMT Study.
 
Center of Community Alliance for Research and Education
CCARE implements specific best practice community strategies to reduce and eliminate inequalities in cancer outcomes. Our mission is to increase education and awareness of the most advanced practices in health care for all patients, bringing the best that City of Hope has to offer to underrepresented and underserved patients and communities.
 
Clinical Trials
At any given time, our researchers are conducting hundreds of clinical trials to test new treatments for cancer. Recruiting diverse participants to these trials allows us to better understand how cancer and its treatments impact different communities and people differently. Our clinical trials improve health.
 
 
Serving Our Latino Community
 
Given that cancer is the leading cause of death among Latinos in California, and recognizing that our primary service area is 46% Latino, we are taking more active steps to better understand and serve the Latino community.

Learn more about the current initiatives at City of Hope aimed at connecting with our Latino community.
 
Contact us at diversityandinclusion@coh.org for more information.
We're a community of people characterized by our diversity of thought, background and approach.
 
We have career opportunities in nursing, research, allied health, business support and many other areas.
 
City of Hope employees enjoy excellent benefits and an environment that inspires wellness.
 
In addition to our main campus in Duarte, CA, we have several locations throughout the Los Angeles vicinity.
 
Current employees and external candidates are invited to explore our career opportunities.
 
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
NEWS & UPDATES
  • Beyond the pink ribbons, special product fundraisers, and the pastel sea of color that marks October, Breast Cancer Awareness Month offers a reason to celebrate and to reflect. More than 2.8 million breast cancer survivors live in the U.S. They are survivors of the second most-common cancer in women, behind ski...
  • Gliomas, a type of tumor that grows in the brain, are very difficult to treat successfully due to their complex nature. That might not always be the case. First some background: The most aggressive and common type of primary brain tumor in adults is glioblastoma. Although the brain tumor mass can often be remov...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. The result is rashes and, sometimes, tumors, which can be mistaken for other dermatological conditions. In a smal...
  • Weighing your breast cancer risk? One study suggests a measure to consider is skirt size. A British study suggests that for each increase in skirt size every 10 years after age 25, the five-year risk of developing breast cancer postmenopause increases from one in 61 to one in 51 – a 77 percent increase in risk....
  • Runners prize medals for 5Ks and marathons. Becky Stokes has a medal she cherishes from a very different kind of race: the marathon of treatments necessary to beat her aggressive triple-negative breast cancer. Just a week ago, she completed her last radiation treatment, and danced in the hospital with the staff...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. Darakjian’s s...
  • The environment plays a role in causing cancer – this much we know. But scientists are still trying to understand what that role is, what environmental factors are in play and how precisely those factors are linked to cancer. Now City of Hope researchers have unlocked a clue as to how one carcinogen triggers ca...
  • Jonathan Yamzon, M.D., assistant clinical professor of surgery in the Division of Urology and Urologic Oncology, explains his approach to what’s known as “active surveillance” of men with prostate cancer. Patients need to be educated about their treatment options, he writes. Active surveillanc...
  • For most prostate cancer patients, surgery or radiation therapy is the initial and primary treatment against the disease. But some patients can benefit from chemotherapy and hormone therapy too, especially if there are signs of a relapse or if the cancer has spread beyond the prostate gland. Here, Cy Stein, M.D...
  • Cancer research has yielded scientific breakthroughs that offer patients more options, more hope for survival and a higher quality of life than ever before. The 14.5 million cancer patients living in the United States are living proof that cancer research saves lives. Now, in addition to the clinic, hospital an...
  • Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life. Howeve...
  • While health care reform has led to an increase in the number of people signing up for health insurance, many people remain uninsured or are not taking full advantage of the health benefits they now have. Still others are finding that, although their premiums are affordable, they aren’t able to see the do...
  • Kidney cancer rates and thyroid cancer rates in adults have continued to rise year after year. Now a new study has found that incidence rates for these cancers are also increasing in children — particularly in African-American children. The study, published online this month in Pediatrics, examined childhood ca...
  • Thyroid cancer has become one of the fastest-growing cancers in the United States for both men and women. The chance of being diagnosed with the cancer has nearly doubled since 1990. This year an estimated 63,000 people will be diagnosed with thyroid cancer in the United States and nearly 1,900 people will die ...
  • Older teenagers and young adults traditionally face worse outcomes than younger children when diagnosed with brain cancer and other central nervous system tumors. A first-of-its-kind study shows why. A team of researchers from the departments of Population Sciences and Pathology at City of Hope recently examine...